Clinical Remissions In Three Otherwise Intractable Cancers Signal The ...
Epeius Biotechnologies Corporation announced more stunning results of its pioneering clinical studies of Rexin-G, the world's first and, so far only, tumor-targeted genetic medicine to be validated in the clinic.
Join the discussion below, or Read more at MediLexicon.
#1 Oct 14, 2009
This agent has orphan drug status via the FDA as well as Fast Track Designation in a number of solid tumors, so it is probably not without some credibility.
I wonder why on earth is there nothing in the prostate cancer literature or web sites about it?
#2 Sep 23, 2013
I have ordered 2 times from this website PILLSMEDSHOP. COM . I called yesterday the customer care and asked for a discount as i was about to order twice the regular amount.
Add your comments below
|Psychological intervention reduces fear of recu...||Jun 6||Humanspirit||1|
|Vaccine may cut HPV infections, an oral cancer ...||May '17||HPV conjob||1|
|Parker Hughes Cancer center suspending operations (Feb '08)||Apr '17||Laura||17|
|Benign tumor||Mar '17||Bharath k||1|
|Myriad Genetics Announces an Assay that Identif... (Nov '16)||Feb '17||Purplemouse2||8|
|Holzer receives donation from Fruth pharmacies||Jan '17||Steve||1|
|New team players: Palliative care specialists f...||Jan '17||Death||3|
Find what you want!
Search Oncology Forum Now
Copyright © 2017 Topix LLC